Avertto is a startup brand dedicated to enabling early intervention and treatment for strokes. Their vision is to prevent disability and improve the quality of life for individuals at risk of stroke. Avertto offers a continuous, wearable hemodynamic monitoring system that detects changes in blood flow to the brain, specifically large vessel occlusions.

This innovative system provides automated alerts, allowing for prompt medical attention and possible treatment. The brand's mission is to provide personal, noninvasive, and convenient home telemonitoring for stroke, reducing morbidity and mortality through timely detection. Avertto values action, prevention, wellness, positivity, resilience, passion, learning, education, trust, safety, quality assurance, risk management, gender equality, good faith, growth, responsiveness, telehealth, home care, the natural environment, and quality-of-life.

Avertto has received recognition and funding for their groundbreaking technology, including being selected as a finalist for the prestigious Aviram Foundation awards. Their experienced multidisciplinary team of clinicians and developers work together to improve healthcare and save lives. With Avertto, strokes can be monitored, detected, and alerted before they occur, allowing for life-saving treatments within the critical Golden Hour